Skip to main content

Raquel Marín - Bibliografía

Nutracéuticos en neuroprotección: la importancia de los ácidos grasos poliinsaturados

Dra. Raquel Marín

BIBLIOGRAFÍA:

  1. Bazinet RP, Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci.2014; 15(12): 771-85.
  2. Casañas V, Perez JA, Fabelo N, et al. Addition of docosahexaenoic acid (DHA), but not arachidonic acid (ARA), activates glutathione and thioredoxin antioxidant systems in murine hippocampal HT22 cells: potential implications in neuroprotection. J. Neurochem. 2014; 131 -14; 470 - 483.
  3. Diaz M, Fabelo N, Ferrer I, et al. Biophysical alterations in lipid rafts from human cerebral cortex associate with increased BACE1/AβPP interaction in early stages of Alzheimer's disease. Journal Alzheimer's Dis. 2015 : 43; 1185 - 1198.
  1. Diaz M, Fabelo N, Martin V, et al. Biophysical alterations in lipid rafts from human cerebral cortex associate 2 with increased BACE1/APP interaction in early stages of Alzheimer's disease. J. Alzheimer's Dis. 2014: 43; 1185 - 1198.
  2. Diaz M, Marin R. Brain polyunsaturated lipids and neurodegenerative diseases. Nutraceuticals and Functional foods Brar et al. (editores). Nova Science Publishers, 2014; 387-412. ISBN: 978-1-62948-783-0.
  3. Elisha B, Guebre-Egziabher F, Vidal H, et al. From French to Mediterranean diet: importance of the omega-6/omega-3 fatty acids ratio. World Rev Nutr Diet. 2011; 102: 81-91. 
  4. Florent-Béchard S, Desbène C, Garcia P, et al. The essential role of lipids in Alzheimer's Disease. Biochimie.2009; 91(6): 804-809.
  5. Gómez Candela C, Bermejo López LM, Loria Kohen V. Importance of a balanced omega 6/omega 3 ratio for the maintenance of health: nutritional recommendations. Nutr Hosp. 2011; 26(2): 323-329.
  6. Grimm MO, Zimmer VC, Lehmann J, et al. The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease. Biomed Res Int.2013; 814390 : 1-16.
  7. Jicha GA, Markesbery WR. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging.2010; 5: 45-61.
  8. Kiefer I, Zifko U. Alimenta tu cerebro. Ediciones Obelisco. 2011. ISBN: 978-84-9777-730-8.
  9. Marin R, Fabelo N, Martin V, et al. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases. Neurobiol. Aging. 2016: 49; 52 - 59.
  10. Marin R, Fabelo N, Fernandez-Echevarria C, et al. Lipid raft alterations in aged-associated neuropathologies. Curr. Alzheimer Res. 2016 : 13; 1 - 12.
  11. Marin R, Rojo JA, Fernandez-Echevarria C, et al. Lipid raft disarrangement as a result of neuropathological progresses: A novel strategy for early diagnosis? Neuroscience. 2013: 245; 26-39.
  1. Marin R. The neuronal membrane as a key factor in neurodegeneration. Frontiers Memb. Physiol. Biophysics. 2013 : 4, 188;1-3.
  2. Marin R. Lipid rafts play a crucial role in protein interactions and intracellular signaling involved in neuronal preservation against Alzheimer’s disease. Lipids and Cellular Membranas in Amyloid Diseases. 2011: 159 -169. ISBN: 978-3-527-32860-4.
  3. Martin V, Fabelo N, Santpere G, et al. Lipid alterations in lipid rafts from Alzheimer’s Disease human brain cortex. J. Alzheimers Dis. 2010; 19(2):489-502. 
  4. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008; 233(6): 674-688.